Clinical Trials Browser

Phase 2 × Terminated × infigratinib × Clear all

NCT06206278 2024-08-14

Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms

NCT02160041 2019-06-18

CBGJ398XUS04

Phase 2 Terminated

84 enrolled 15 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT02706691 2019-04-16

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

Phase 2 Terminated

1 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Neoplasms, Papillomavirus Infections